Filing Details

Accession Number:
0001209191-13-030248
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-03 17:01:38
Reporting Period:
2013-05-30
Filing Date:
2013-06-03
Accepted Time:
2013-06-03 17:01:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
786947 Acura Pharmaceuticals Inc ACUR Pharmaceutical Preparations (2834) 110853640
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1034486 P L Iii Partners Galen C/O Galen Management, L.l.c.
680 Washington Blvd.
Stamford CT 06901
No No Yes No
1034574 P L Iii International Partners Galen C/O Galen Management, L.l.c.
680 Washington Blvd.
Stamford CT 06901
No No Yes No
1056642 Galen Employee Fund Iii Lp C/O Galen Management L.l.c.
680 Washington Blvd.
Stamford CT 06901
No No Yes No
1056643 Claudius Llc C/O Galen Management, L.l.c.
680 Washington Blvd.
Stamford CT 06901
No No Yes No
1421162 Galen Management, Llc 680 Washington Blvd.
Stamford CT 06901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-30 12,860 $2.26 11,864,175 No 4 S Indirect See FN
Common Stock Disposition 2013-05-31 18,699 $2.25 11,845,476 No 4 S Indirect See FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See FN
No 4 S Indirect See FN
Footnotes
  1. The shares were sold as follows: 11,749 by Galen Partners III, L.P. ("Galen III"), 1,063 by Galen Partners International III, L.P. ("Galen International") and 48 by Galen Employee Fund III, L.P. ("Employee Fund").
  2. The shares were sold at prices between $2.25 and $2.27. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares are held as follows: 10,841,646 by Galen III, 977,871 by Galen International and 44,658 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
  4. The shares were sold as follows: 17,083 by Galen III, 1,546 by Galen International and 70 by Employee Fund.
  5. The shares were sold at prices between $2.25 and $2.30. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. The shares are held as follows: 10,824,563 by Galen III, 976,325 by Galen International and 44,588 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.